According to Niagen Bioscience's latest financial reports the company's current EPS (TTM) is 0,18ย โฌ. In 2025 the company made an earnings per share (EPS) of 0,21ย โฌ an increase over its 2024 EPS that were of 0,08924ย โฌ.